Titan Biotech Limited (BOM:524717)

Market Cap	3.49B
Revenue (ttm)	1.56B
Net Income (ttm)	215.32M
Shares Out	8.26M
EPS (ttm)	26.06
PE Ratio	16.23
Forward PE	n/a
Dividend	2.00 (0.47%)
Ex-Dividend Date	Sep 23, 2024

Volume	2,842
Average Volume	7,349
Open	423.55
Previous Close	426.05
Day's Range	418.55 - 428.00
52-Week Range	406.70 - 1,017.85
Beta	0.43
RSI	37.83
Earnings Date	May 29, 2025

About Titan Biotech

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; a...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1992
• Employees: 449
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524717

Financial Performance

In 2024, Titan Biotech's revenue was 1.56 billion, a decrease of -4.65% compared to the previous year's 1.64 billion. Earnings were 215.32 million, a decrease of -13.36%.